Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy 0 18.10.2024 22:21 Fiercepharma.com Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy fkansteiner Fri, 10/18/2024 - 15:21
